Boxer Capital Makes Significant Investment in Vir Biotechnology with Large Share Purchase
In a significant financial move, Boxer Capital Management disclosed the acquisition of 1,241,000 shares of Vir Biotechnology on May 15, 2026, a deal valued at approximately $9.89 million based on quarterly average pricing. This investment underscores a notable confidence in Vir Biotechnology, which…